摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-C-(1-methoxyindol-3-yl)-β-L-xylo-3-hexulofuranosonic acid γ-lactone | 331754-99-5

中文名称
——
中文别名
——
英文名称
2-C-(1-methoxyindol-3-yl)-β-L-xylo-3-hexulofuranosonic acid γ-lactone
英文别名
2-C-[(1-methoxyindol-3-yl)methyl]-α-L-xylo-hex-3-uloforanoso-1,4-lactone;2-C-(1-methoxy-3-indolylmethyl)-α-L-xylo-3-hexulofuranosono-1,4-lactone;1-methoxyascorbigen;N-Methoxyascorbigen;Neoascorbigen;(3S,3aR,6S,6aS)-3,6,6a-trihydroxy-6-[(1-methoxyindol-3-yl)methyl]-3,3a-dihydro-2H-furo[3,2-b]furan-5-one
2-C-(1-methoxyindol-3-yl)-β-L-xylo-3-hexulofuranosonic acid γ-lactone化学式
CAS
331754-99-5
化学式
C16H17NO7
mdl
——
分子量
335.313
InChiKey
RZRVFWGHJJZBJQ-XNISGKROSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    110
  • 氢给体数:
    3
  • 氢受体数:
    7

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-C-(1-methoxyindol-3-yl)-β-L-xylo-3-hexulofuranosonic acid γ-lactone维生素 C 作用下, 以 为溶剂, 反应 48.0h, 以27%的产率得到2-hydroxy-4-hydroxymethyl-3-(1-methoxylindol-3-yl)-cyclopent-2-enone
    参考文献:
    名称:
    The formation of 2-hydroxy-4-hydroxymethyl-3-(indol-3-yl)cyclopent-2-enone derivatives from ascorbigens
    摘要:
    A facile preparation is described of 3-(indol-3-yl)-2-hydroxy-4-hydroxymethylcyclopent-2-enone and its N-derivatives in 15-40% yields by the degradation of ascorbigen or its N-derivatives in a warm solution of L-ascorbic acid through a sequential domino reaction. The same cyclopentenone derivatives were obtained in 30-40% yields by the condensation of (N-alkylindol-3-yl)glycolic acids with ascorbic acid. 2,6-Dihydroxy-1-(indol-3-yl)hexa-1,4-diene-3-one and 2-hydroxy-4-hydroxymethyl-5-(indol-3-yl)cyclopent-2-enone were identified as intermediates in this reaction. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0008-6215(00)00310-4
  • 作为产物:
    描述:
    1-甲氧基-1H-吲哚-3-甲醛 在 sodium tetrahydroborate 、 citrate-phosphate buffer 作用下, 以 乙醇 为溶剂, 反应 16.17h, 生成 2-C-(1-methoxyindol-3-yl)-β-L-xylo-3-hexulofuranosonic acid γ-lactone
    参考文献:
    名称:
    Investigation of neoascorbigen
    摘要:
    DOI:
    10.1007/bf02283542
点击查看最新优质反应信息

文献信息

  • Study of 1-deoxy-1-(indol-3-yl)-l-sorbose, 1-deoxy-1-(indol-3-yl)-l-tagatose, and their analogs
    作者:Sergey N Lavrenov、Alexander M Korolev、Marina I Reznikova、Andrey V Sosnov、Maria N Preobrazhenskaya
    DOI:10.1016/s0008-6215(02)00404-4
    日期:2003.1
    Alkaline degradation of the ascorbigen 2-C-[(indol-3-yl)methyl]-alpha-L-xylo-hex-3-ulofuranosono-1,4-lactone (1a) led to a mixture of 1-deoxy-1-(indol-3-yl)-L-sorbose (2a) and 1-deoxy-1-(indol-3-yl)-L-tagatose (3a). The mixture of diastereomeric ketoses underwent acetylation and pyranose ring opening under the action of acetic anhydride in pyridine in the presence of 4-dimethylaminopyridine (DMAP)
    抗坏血酸2-C-[((吲哚-3-基)甲基]-α-L-二甲苯基-hex-3-ulofuranosono-1,4-内酯(1a)的碱性降解导致1-deoxy-1的混合物-(吲哚-3-基)-L-山梨糖(2a)和1-脱氧-1-(吲哚-3-基)-L-塔格糖(3a)。非对映体酮糖的混合物在4-二甲基氨基吡啶(DMAP)存在下,在乙酸酐的吡啶中,在乙酸酐的作用下进行乙酰化和吡喃糖开环,形成(E)-2,3,4,5,6-混合物五-O-乙酰基-1-脱氧-1-(吲哚-3-基)-L-木基-己基-1-烯醇(4a)和(E)-2,3,4,5,6-penta-O -乙酰基-1-脱氧-1-(吲哚-3-基)-L-lyxo-己基-1-烯醇(5a),将其色谱分离。4a或5a脱乙酰基提供环化的四醇,将其甲苯磺酸化混合可生成1-deoxy-1-(吲哚-3-yl)-3,5-di-O-甲苯磺酰基-α-L-山梨糖醛糖(12a)和1 -脱氧-
  • Synthesis and study of neoscorbigen and its analogs
    作者:V. I. Mukhanov、M. M. Kaganskii、A. A. Sorokin、S. G. Antonyan、G. V. Tananova、L. L. Mikhailevskaya、A. S. Kinzirskii、M. N. Preobrazhenskaya
    DOI:10.1007/bf02219244
    日期:1994.7
  • From ascorbigens to indolocarbazoles
    作者:Maria N. Preobrazhenskaya、Alexander M. Korolev、Ilya I. Rozhkov、Larisa N. Yudina、Eduard I. Lazhko、Enrico Aiello、Anna Maria Almerico、Francesco Mingoia
    DOI:10.1016/s0014-827x(99)00026-9
    日期:1999.5
    New methods of L-ascorbic acid derivatization with the use of polyfunctional indole-3-cabinols are described. Reaction of beta-hydroxy-N-methyltryptamine and L-ascorbic acid gave lactame derivatives; (indol-3-yl)glycolic and L-ascorbic acids produced 2-hydroxy-4-hydroxymethyl-3-(indol-3-yl) Similarly, 4-hydroxy-3-methoxyphenylglycolic and L-ascorbic acids yielded 2-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-4-hydroxymethyl-cyclopen-2-enone. Properties of N-methoxyascorbigen (neoascorbigen) were investigated. Alkylation of L-ascorbic acid with polysubstituted pyrrolecarbinols led to pyrrole analogues of ascorbigen. Acidic transformation of 3-formylindole and 1-methyl-3-formylindole led to indolocarbazoles and triindolyhmethane derivatives. (C) 1999 Elsevier Science S.A. All rights reserved.
  • The formation of 2-hydroxy-4-hydroxymethyl-3-(indol-3-yl)cyclopent-2-enone derivatives from ascorbigens
    作者:Alexander M Korolev、Larisa N Yudina、Ilyia I Rozhkov、Ludmila N Lysenkova、Eduard I Lazhko、Yury N Luzikov、Maria N Preobrazhenskaya
    DOI:10.1016/s0008-6215(00)00310-4
    日期:2001.2
    A facile preparation is described of 3-(indol-3-yl)-2-hydroxy-4-hydroxymethylcyclopent-2-enone and its N-derivatives in 15-40% yields by the degradation of ascorbigen or its N-derivatives in a warm solution of L-ascorbic acid through a sequential domino reaction. The same cyclopentenone derivatives were obtained in 30-40% yields by the condensation of (N-alkylindol-3-yl)glycolic acids with ascorbic acid. 2,6-Dihydroxy-1-(indol-3-yl)hexa-1,4-diene-3-one and 2-hydroxy-4-hydroxymethyl-5-(indol-3-yl)cyclopent-2-enone were identified as intermediates in this reaction. (C) 2001 Elsevier Science Ltd. All rights reserved.
  • Investigation of neoascorbigen
    作者:L. N. Yudina、A. M. Korolev、M. I. Reznikova、M. N. Preobrazhenskaya
    DOI:10.1007/bf02283542
    日期:2000.2
查看更多

同类化合物

顺式-2,3,3a,6a-四氢呋喃[2,3-b]呋喃 莱克酮 索尼地平 硝酸异山梨酯 溴化二氢6-(联苯基-4-基)-3-氯-12,13-二甲氧基-9,10--7H-异奎并[2,1-d][1,4]苯并二氮卓-8-正离子 星形曲霉毒素 抗坏血酸原 A 异山梨醇二甲基醚 异山梨醇13C65-单酸酯 异山梨醇 失水甘露醇单油酸酯 失水甘露醇单油酸酯 大青素 地瑞那韦中间体1 四氢呋喃[2,3-B]呋喃-2(6AH)-酮 四氢-6a-甲基-呋喃并[2,3-b]呋喃-2(3H)-酮 四氢-6-硫代-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3-酮 去甲斑蝥素 单-9-十八烯酸1,4:3,6-双脱水-D-甘露醇酯 华北白前甙元B 六氢呋喃并[2,3-b]呋喃-3-醇 六氢呋喃并[2,3-b]呋喃 六氢-呋喃并[2,3-b]呋喃-3-醇 二氯萘 二氢-1,4-二甲基-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二酮 二氢-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二酮 二氢-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二硫酮 乙酸异山梨醇酯 丙氨酸,N-(5-氯-2-羟基苯甲酰)- N-乙酰基-L-丙氨酰-L-酪氨酸 L-葡糖酸-3,6-内酯 D-葡糖醛酸-γ-内酯丙酮化合物 D-甘露呋喃糖醛酸 gamma-内酯 BISTHFHNS衍生物3 7H,10H-呋喃并[2,3,4-cd]萘并[2,1-e]异苯并呋喃-7-酮,十四氢-10-羟基-1,1,4a-三甲基-,(4aS,4bR,6aR,8aR,10R,10aS,10bR,12aS)-(9CI) 7-氧杂二环[2.2.1]庚-5-烯-2,3-二羧酸酐 6H,9H-苯并[e]呋喃并[2,3,4-cd]异苯并呋喃-6-酮,2,4,4a,5,7,8,10a,10b-八氢-5,5-二甲基-,(4aR,8aR,10aR,10bS)-(9CI) 6-[(1E,3E,5E)-6-[(1R,2R,3R,5R,7R,8R)-7-乙基-2,8-二羟基-1,8-二甲基L-4,6-二氧杂双环[3.3.0]辛-3-基]己-1,3,5-三烯基]-4-甲氧基-5-甲基-吡喃-2-酮 5-单硝酸异山梨酯 5-[(4,6-二氯-1,3,5-三嗪-2-基)氨基]-4-羟基-3-[(4-磺酸根-1-萘基)偶氮]萘-2,7-二磺化三钠 5,6-二溴-7-氧杂双环[2.2.1]庚烷-2,3-二甲酸酐 5,5-二甲基-4,8-二氧杂三环[4.2.1.03,7]壬-2-基丙烯酸酯 4-硝基苯并[pqr]四苯-1-醇 4,10-二氧杂三环[5.2.1.0(2,6)]癸-8-烯-3-酮 4,10-二氧杂三环[5.2.1.0(2,6)]癸-8-烯-3,5-二酮 3-脱氧-14,15-二氢-15-羟基-莸酯素醇 3-亚甲基六氢呋喃并[2,3-b]呋喃 3-(2,3-二溴-4,5-二羟基苯甲基)-3a,6-二羟基-3-甲氧基四氢呋喃并[3,2-b]呋喃-2(3H)-酮(non-preferredname) 2a,3,5,6,11a,11b-六氢-3-羟基-2a,6,10-三甲基-3-(1-甲基丙基)-6,9-环氧-2H-1,4-二氧杂环癸[cd]并环戊二烯-2,7(4ah)-二酮 2-硝酸异山梨酯(STORE BELOW +4 DEGR C)